Skip to Content
Merck
CN

Key Documents

View All Documentation

336971

Tripropylphosphine

97%, liquid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
(CH3CH2CH2)3P
CAS Number:
2234-97-1
Molecular Weight:
160.24
NACRES:
NA.22
PubChem Substance ID:
24860445
UNSPSC Code:
12352001
EC Number:
218-786-0
MDL number:
MFCD00015217
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Tripropylphosphine, 97%

assay

97%

form

liquid

reaction suitability

reaction type: Buchwald-Hartwig Cross Coupling Reaction, reaction type: Heck Reaction, reaction type: Hiyama Coupling, reaction type: Negishi Coupling, reaction type: Sonogashira Coupling, reaction type: Stille Coupling, reaction type: Suzuki-Miyaura Coupling, reagent type: ligand

refractive index

n20/D 1.4584 (lit.)

bp

72-74 °C/12 mmHg (lit.)

density

0.801 g/mL at 25 °C (lit.)

functional group

phosphine

SMILES string

CCCP(CCC)CCC

InChI

1S/C9H21P/c1-4-7-10(8-5-2)9-6-3/h4-9H2,1-3H3

InChI key

KCTAHLRCZMOTKM-UHFFFAOYSA-N

pictograms

FlameCorrosion
GHS02,GHS05

signalword

Danger

hcodes

H250,H314

Hazard Classifications

Eye Dam. 1 - Pyr. Liq. 1 - Skin Corr. 1B

Storage Class

4.2 - Pyrophoric and self-heating hazardous materials

wgk

WGK 3

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
SHBK1437
SHBH4690V
SHBF5103V
36096KM
03197JJ

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Johannes Wiest et al.
Journal of controlled release : official journal of the Controlled Release Society, 268, 314-322 (2017-11-04)
Poor water solubility of drugs fuels complex formulations and jeopardizes patient access to medication. Simplifying these complexities we systematically synthesized a library of 36 sterically demanding counterions and mapped the pharmaceutical design space for amorphous ionic liquid strategies for Selurampanel
Rahul A Patil et al.
Analytical and bioanalytical chemistry, 410(19), 4645-4655 (2018-01-31)
The rapid expansion in the study and use of ionic liquids (ILs) is a result of their unique properties including negligible volatility, high thermal stability, and ability to dissolve disparate compounds. However, because ILs have infinitely variable structures (often referred

Global Trade Item Number

SKUGTIN
336971-25G04061838119377
336971-5G04061838126634